High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line
Suzuki Takahiro, Huang Ming-Chih, Adati Naoki and 2 more
BMC Research Notes · 2009
doi:10.1186/1756-0500-2-153 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>THP-1 is a human monocytic leukemia cell line derived from a patient with acute monocytic leukemia. The cell line differentiates into macrophage-like cells by stimulation with phorbol myristate acetate (PMA). Although it has been used frequently as a model for macrophage differentiation in research including the FANTOM4/Genome Network Project, there are few reports on its genomic constitution. Therefore, we attempted to reveal the genomic aberrations in these cells with the microarray-based comparative genomic hybridization (aCGH) technique.</p> <p>Findings</p> <p>We report large aberrations, including deletions 6p, 12p, 17p, and trisomy 8, and revealed breakpoints in the <it>MLL </it>and <it>MLLT3 </it>genes. Moreover, we found novel genomic aberrations such as a hemizygous narrow deletion partially containing the <it>TP73 </it>gene and homozygous deletions, including the <it>CDKN2A</it>, <it>CDKN2B </it>and <it>PTEN </it>genes.</p> <p>Conclusion</p> <p>In this study, we identified 119 aberrant regions in autosomal chromosomes, and at least 16 of these aberrations were less than 100 kb, most of which were undetectable in the previous works. We also revealed a total of 4.6 Mb of homozygous deleted regions. Our results will provide a base to precisely understand studies involving the THP-1 cell line, especially the huge amount of data generated from the FANTOM4/Genome Network Project.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.